...
首页> 外文期刊>Genome Biology >Highly interconnected genes in disease-specific networks are enriched for disease-associated polymorphisms.
【24h】

Highly interconnected genes in disease-specific networks are enriched for disease-associated polymorphisms.

机译:疾病特定网络中高度互连的基因丰富了与疾病相关的多态性。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Complex diseases are associated with altered interactions between thousands of genes. We developed a novel method to identify and prioritize disease genes, which was generally applicable to complex diseases. RESULTS: We identified modules of highly interconnected genes in disease-specific networks derived from integrating gene-expression and protein interaction data. We examined if those modules were enriched for disease-associated SNPs, and could be used to find novel genes for functional studies. First, we analyzed publicly available gene expression microarray and genome-wide association study (GWAS) data from 13, highly diverse, complex diseases. In each disease, highly interconnected genes formed modules, which were significantly enriched for genes harboring disease-associated SNPs. To test if such modules could be used to find novel genes for functional studies, we repeated the analyses using our own gene expression microarray and GWAS data from seasonal allergic rhinitis. We identified a novel gene, FGF2, whose relevance was supported by functional studies using combined small interfering RNA-mediated knock-down and gene expression microarrays. The modules in the 13 complex diseases analyzed here tended to overlap and were enriched for pathways related to oncological, metabolic and inflammatory diseases. This suggested that this union of the modules would be associated with a general increase in susceptibility for complex diseases. Indeed, we found that this union was enriched with GWAS genes for 145 other complex diseases. CONCLUSIONS: Modules of highly interconnected complex disease genes were enriched for disease-associated SNPs, and could be used to find novel genes for functional studies.Registry Number/Name of Substance 0 (RNA, Small Interfering). 103107-01-3 (Fibroblast Growth Factor 2).
机译:背景:复杂的疾病与数千个基因之间相互作用的改变有关。我们开发了一种新颖的方法来识别疾病基因并确定其优先级,该方法通常适用于复杂疾病。结果:我们确定了疾病特异性网络中高度互连的基因模块,这些模块是通过整合基因表达和蛋白质相互作用数据得出的。我们检查了这些模块是否丰富了与疾病相关的SNP,并可以用于寻找功能性研究的新基因。首先,我们分析了来自13种高度复杂的复杂疾病的可公开获得的基因表达微阵列和全基因组关联研究(GWAS)数据。在每种疾病中,高度相互关联的基因形成模块,这些模块显着富集了与疾病相关的SNP的基因。为了测试此类模块是否可用于寻找新的基因进行功能研究,我们使用自己的基因表达微阵列和季节性变应性鼻炎的GWAS数据重复进行了分析。我们确定了一个新的基因,FGF2,其相关性得到了功能研究的支持,该研究使用了组合的小干扰RNA介导的敲低和基因表达微阵列。此处分析的13种复杂疾病中的模块趋于重叠,并丰富了与肿瘤,代谢和炎性疾病相关的途径。这表明模块的这种结合将与复杂疾病易感性的普遍增加有关。确实,我们发现该联合体富含GWAS基因,可用于145种其他复杂疾病。结论:高度互连的复杂疾病基因模块丰富了疾病相关的SNP,可用于寻找新的基因进行功能研究。登记号/物质0的名称(RNA,小干扰)。 103107-01-3(成纤维细胞生长因子2)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号